Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300243
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,215
Award facts
- Contract value 100% obligated
- $5,215.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, was awarded a $5,215.20 blanket purchase agreement (BPA) call for drugs and biologicals on May 16, 2013, by a civilian federal agency under the Office of the Director. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for ultimate completion on February 28, 2014. Performance will take place in Rockford, Illinois. As a BPA call, this award represents a task order placed against an existing blanket purchase agreement vehicle, enabling the ordering agency to procure needed supplies without conducting a new competitive solicitation.
Pierce Biotechnology, operating within the Thermo Electron Corporation portfolio of scientific instrument providers, supplies pharmaceutical and biological products to federal agencies. Thermo Electron Corporation has established itself as a significant federal contractor providing analytical instrumentation and related services across multiple agencies, including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency. The modest contract value of approximately $5.2K indicates this particular call represents a relatively small procurement action against the broader BPA framework maintained by the parent corporation to support ongoing federal requirements for scientific and biological supplies.
Quick answers
Who was awarded contract HHSN26300243?
HHSN26300243 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on May 16, 2013.
How much is contract HHSN26300243 worth?
The government has obligated $5,215 on HHSN26300243.
Is contract HHSN26300243 an order under another contract?
Yes. HHSN26300243 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300243 competed?
The extent of competition for HHSN26300243 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award